Data just published in Nature Biotechnology suggests that a new type of PSA test developed by a company called Quanterix is 1,700 times more sensitive than older, standard PSA detection methods used in clinical laboratories. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Risk | Tagged: PSA, Quanterix, sensitive, test | 3 Comments »
